Market demand surged, and the "oximeter" concept stock rose sharply today

【Pharmaceutical Network Pharmaceutical Stock Market】 Recently, oximeters have become a hot epidemic prevention product
.
According to the Baidu index, in the past week, the daily average value of the oximeter search index was 19859, an increase of 187% month-on-month and 8771%
year-on-year.
At 9:40 on December 28, the oximeter sector index reported 1011.
837 points, an increase of 5%, with a transaction of 1.
606 billion yuan and a turnover rate of 1.
24%.

Among the individual stocks in the sector, the top 5 stocks with large gains were: Paulette reported 18.
37 yuan, up 12.
49%; Aojiahua reported 10.
01 yuan, up 10.
00%; Kangtai Medical reported 31.
98 yuan, up 6.
60%; Lipon Instruments reported 12.
78 yuan, up 6.
23%; Kefu Medical reported 37.
00 yuan, up 3.
82%.

It is reported that Bolette has said on the interactive platform that the company's M70 series pulse oximeter is convenient to carry, compact in structure, and the data is clear and easy to read, which is suitable for household blood oxygen saturation measurement
.
Paulette has said that the production of household oximeters is mainly an assembly link, so the increase in production is mainly to do several production lines, and the production capacity is expanded rapidly
.
Recently, Baolaite also said that it will maintain relatively reasonable inventory according to market demand and past sales, and always have insight into the market reaction and future development trends to adjust and ensure supply
.
On December 28, Aojiahua touched the limit board, and the stock has risen five times
in the past year.
It is reported that on December 19, 2022, Aojiahua Interactive replied: The oximeters and other products of the company's brand Medisana are retailed
on e-commerce platforms such as Jingdong and Tmall.
Kangtai Medical recently said on the interactive platform that the company is one of the earliest enterprises in China to develop, produce and sell oximeters, and is also one of the world's large-scale oximeter suppliers, with a whole industry chain production mode and mass production capabilities of oximeters
.
Recently, the downstream demand for domestic oximeters has surged, and the company has increased production lines
according to orders.
At present, the daily output of oximeters exceeds 100,000 sets, and the subsequent company will continue to expand production capacity according to orders and market demand, and do its best to meet the order demand
.
The relevant person in charge of Kangtai Medical said, "Because the oximeter can monitor the blood oxygen saturation in real time and detect abnormal respiratory system as soon as possible, the market demand for oximeter is strong
in the near future.
" With the increasing awareness of self-health and the growing demand for health management, it will become the main driving factor
for the incremental expansion of the oximeter market.
Leebang Instruments responded to the interaction on December 21, 2022: The company's business-related equipment mainly includes patient monitors, electrocardiogram machines, blood gas analyzers, and household finger oximeters
.
Kefu Medical also replied on December 22, 2022: The company has a rich product category, among which health monitoring products include thermometers, oximeters, antigen detection kits and other products, which can be used for daily health monitoring needs
.
The new concept of "oximeter" has made some companies widely concerned
.
However, analysts pointed out that although the demand for oximeters has grown highly, in the secondary market, the stock price of oximeter concept stocks has not fluctuated as much as the previous pharmaceutical sector, and has only risen
slightly.
As of the close of trading on December 27, the stock prices of Libon Instruments, Kangtai Medical, Yuyue Medical and Lepu Medical were reported at 12.
03 yuan / share, 30 yuan / share, 31.
31 yuan / share, and 21.
93 yuan / share, respectively, up 4.
15%, 5.
85%, 2.
4% and 1.
57%
from the "silent hypoxia" view appeared on the Internet on December 21.
For the market demand for oximeters, most companies said that the company's production line is in normal production and will actively ensure supply, but it is impossible to judge whether the hot sales of oximeters will affect
the company's performance.
For example, Yuyue Medical said on the investor interactive platform that the company has continued to provide a variety of products and related solutions
such as respiratory oxygen production, disinfection and infection control, blood oxygen, and body temperature detection for the frontline of anti-epidemic including in-hospital and out-of-hospital hospitals.
At present, the company's production and operation are stable and orderly, and it will reasonably arrange the production plan according to market demand and orders, do its best to respond to relevant material needs, and provide product support
for medical institutions and individuals.
Disclaimer: Under no circumstances does the information or opinions expressed herein constitute investment advice
to anyone.